...
首页> 外文期刊>Journal of chemical information and modeling >A Novel Structure-Based Multimode QSAR Method Affords Predictive Models for Phosphodiesterase Inhibitors
【24h】

A Novel Structure-Based Multimode QSAR Method Affords Predictive Models for Phosphodiesterase Inhibitors

机译:一种新型的基于结构的多模态QSAR方法Affords磷酸二酯酶抑制剂的预测模型。

获取原文
获取原文并翻译 | 示例
           

摘要

Quantitative structure-activity relationship (QSAR) methods aim to build quantitatively predictive models for the discovery of new molecules. It has been widely used in medicinal chemistry for drug discovery. Many QSAR techniques have been developed since Hansch’s seminal work, and more are still being developed. Motivated by Hopfinger’s receptor-dependent QSAR (RD-QSAR) formalism and the Lukacova-Balaz scheme to treat multimode issues, we have initiated studies that focus on a structurebased multimode QSAR (SBMM QSAR) method, where the structure of the target protein is used in characterizing the ligand, and the multimode issue of ligand binding is systematically treated with a modified Lukacova-Balaz scheme. All ligand molecules are first docked to the target binding pocket to obtain a set of aligned ligand poses. A structure-based pharmacophore concept is adopted to characterize the binding pocket. Specifically, we represent the binding pocket as a geometric grid labeled by pharmacophoric features. Each pose of the ligand is also represented as a labeled grid, where each grid point is labeled according to the atom types of nearby ligand atoms. These labeled grids or three-dimensional (3D) maps (both the receptor map (R-map) and the ligand map (L-map)) are compared to each other to derive descriptors for each pose of the ligand, resulting in a multimode structure-activity relationship (SAR) table. Iterative partial leastsquares (PLS) is employed to build the QSAR models. When we applied this method to analyze PDE-4 inhibitors, predictive models have been developed, obtaining models with excellent training correlation (r~2 = 0.65-0.66), as well as test correlation (R~2 = 0.64-0.65). A comparative analysis with 4 other QSAR techniques demonstrates that this new method affords better models, in terms of the prediction power for the test set.
机译:定量构效关系(QSAR)方法旨在建立用于发现新分子的定量预测模型。它已被广泛用于药物发现的药物化学中。自Hansch开创性工作以来,已经开发了许多QSAR技术,并且仍在开发中。受Hopfinger依赖受体的QSAR(RD-QSAR)形式主义和Lukacova-Balaz方案治疗多模态问题的启发,我们已开始着重研究基于结构的多模QSAR(SBMM QSAR)方法,其中使用了靶蛋白的结构在表征配体中,配体结合的多模问题已用改良的Lukacova-Balaz方案系统地处理。首先将所有配体分子对接至靶标结合口袋,以获得一组对齐的配体姿势。采用基于结构的药效团概念来表征结合口袋。具体来说,我们将结合袋表示为用药效学特征标记的几何网格。配体的每个位姿也表示为标记的网格,其中每个网格点均根据附近配体原子的原子类型进行标记。将这些标记的网格或三维(3D)映射(受体映射(R-map)和配体映射(L-map))相互比较,以得出配体每个姿势的描述符,从而形成多模结构-活动关系(SAR)表。迭代偏最小二乘(PLS)用于构建QSAR模型。当我们将该方法用于分析PDE-4抑制剂时,已经建立了预测模型,获得了具有良好训练相关性(r〜2 = 0.65-0.66)和测试相关性(R〜2 = 0.64-0.65)的模型。与其他4种QSAR技术的比较分析表明,就测试集的预测能力而言,该新方法可提供更好的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号